The impact of a reformulation of extended-release oxycodone designed to deter abuse in a sample of prescription opioid abusers

In this sample, abuse of reformulated ERO was low, and lower than abuse of original ERO retrospectively and IR oxycodone concurrently, particularly through injecting and snorting routes of administration. There was no evidence to suggest that reformulated ERO became a substitute for original ERO.